PNC Financial Services Group’s Terns Pharmaceuticals TERN Stock Holding History

PNC Financial Services Group’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$109K	Buy	2,060 +1,124	+120%	+$46.2K	﹤0.01%	2757
2025 Q4	$37.8K	Sell	936 -147	-14%	-$3.4K	﹤0.01%	3363
2025 Q3	$8.13K	Buy	1,083 +304	+39%	+$1.94K	﹤0.01%	4017
2025 Q2	$2.91K	Buy	779 +296	+61%	+$924	﹤0.01%	4303
2025 Q1	$1.33K	Buy	+483	New	+$1.97K	﹤0.01%	4458
2024 Q2	–	Sell	-17	Closed	-$112	–	4916
2024 Q1	$112	Buy	17 +9	+113%	+$59	﹤0.01%	4644
2023 Q4	$52	Buy	+8	New	+$42	﹤0.01%	4560

Other funds holding TERN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

PNC Financial Services Group's TERN Position: Q1 2026 in Review

PNC Financial Services Group increased its Terns Pharmaceuticals (TERN) stake by 120% in Q1 2026, buying an estimated $46.2K and bringing the position to 2,060 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #2757.

PNC Financial Services Group first reported a position in TERN in Q4 2023 and has held it in 7 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

PNC Financial Services Group held 2,060 shares of Terns Pharmaceuticals worth $109K as of Q1 2026.
PNC Financial Services Group bought 1,124 Terns Pharmaceuticals shares in Q1 2026, an estimated $46.2K.
Terns Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2757 holding.
PNC Financial Services Group first reported a position in Terns Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.